Syncom Formulations (India) Limited (NSE: SYNCOMF), ISIN INE312C01025 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SYNCOMF last traded at ₹13.10 (-0.83%), with a 52-week range of ₹10.21 to ₹19.09 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 50.57%, FIIs 0.35%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 61/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.